Portfolio company
Nanograb
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops an artificial intelligence platform to design targeted gene delivery vectors and nanoparticles for pharmaceutical organisations developing genetic medicines.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
ZipBio
The company develops artificial intelligence to design gene therapies for pharmaceutical firms and biotechnology researchers.
Inceptive Nucleics
This company develops artificial intelligence models to design novel RNA-based medicines and biotechnologies for pharmaceutical and biotechnology partners.
Whitelab Genomics
Whitelab Genomics develops an AI-powered software platform for designing and optimising genomic medicines for biotechnology companies, pharmaceutical firms, and academic research organisations.
AI-enabled drug design
This company develops generative machine learning platforms to design and optimise small-molecule drug candidates for pharmaceutical and biotechnology partners.
Dyno Therapeutics
The company designs adeno-associated virus vectors for gene delivery using artificial intelligence for biopharmaceutical and pharmaceutical partners.
Prosemble
This biotechnology company develops an artificial intelligence and nanotechnology platform to design protein-based nanoparticle systems for precise drug delivery to cancer patients.
expressionedits
This company develops a computational platform using artificial intelligence to optimise gene design and enhance protein production for biotechnology and pharmaceutical organisations.
Spot Biosystems
This company develops non-viral gene therapy delivery platforms using extracellular vesicles to treat genetic diseases for pharmaceutical partners and healthcare providers.
